Open AccessPractical consensus recommendations on ovarian suppression in early breast cancer (adjuvant)
Author(s) -
Manish Singhal,
TP Sahoo,
Sandeep Aggarwal,
Aditi Singhvi,
Vikrant Kaushal,
Sajjan Rajpurohit,
KM Parthasarthi,
Amish Vora,
Madhusudan Ganvir,
Sudeep Gupta,
Purvish M. Parikh
Publication year - 2018
Publication title -
south asian journal of cancer
Language(s) - English
Resource type - Journals
eISSN - 2278-4306
pISSN - 2278-330X
DOI - 10.4103/sajc.sajc_125_18
Subject(s) - medicine , breast cancer , oncology , adjuvant , ovarian cancer , stage (stratigraphy) , consensus conference , adjuvant therapy , expert opinion , gynecology , cancer , intensive care medicine , paleontology , biology
Substantial survival benefits exist for patients with early-stage breast cancer who undergo treatment with single-modality ovarian suppression, but its value is uncertain. Expert oncologist discussed to determine whether additional benefits exist with ovarian suppression plus multiple adjuvant therapy which provides a new treatment option that reduces the risk of recurrence in early breast cancer. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at this practical consensus recommendations for the benefit of community oncologists.